Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AID System in Adult T1DM
NCT03367390Phase 1Completed
- Sponsor
- Eli Lilly and Company
- Start
- Nov 2017
- Primary completion
- Feb 2018
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by Eli Lilly and Company. Primary endpoints: Number of Participants Who Show a Decrease or Suspension of Basal Insulin Delivery in Response to Hypoglycemia Challenges, Number of Participants Who Show an Increase of Basal Insulin Delivery in Response to the Hyperglycemia Challenge and 1 more. Started Nov 2017; status: completed.
Beyond the preview
Go deeper on NCT03367390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03367390.